Trial Profile
A trial to study the effect of pemetrexed in patients with stage IV non-squamous non small cell lung cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2016
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Aug 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology